Volume 9, Number 1, 21-23, DOI: 10.1007/BF01693701

Published in partnership with

Logo

Antipyretic therapy with diclofenac sodium
Observations on effect and serious side effects in critically Ill patients

D. F. Zandstra, C. P. Stoutenbeek and J. P. Alexander

View Related Documents

Abstract

The antipyretic activity of diclofenac sodium, 100 mg suppository was studied retrospectively in 21 applications in seven intensive care patients. Diclofenac sodium proved to be a very potent antipyretic agent with serious side effects. Acute oliguria and protracted circulatory shock occured after administration, necessitating the administration of increasing amounts of dopamine and i.v. fluids. Possible mechanisms involved are discussed.

Key words  Antipyretic therapy - Diclofenac sodium - Acute oliguria - Circulation

Fulltext Preview

Image of the first page of the fulltext document